These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7703282)

  • 41. Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.
    Brenner M; Krance R; Heslop HE; Santana V; Ihle J; Ribeiro R; Roberts WM; Mahmoud H; Boyett J; Moen RC
    Hum Gene Ther; 1994 Apr; 5(4):481-99. PubMed ID: 8049305
    [No Abstract]   [Full Text] [Related]  

  • 42. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 43. An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma.
    Duncan N; Hewetson M; Powles R; Raje N; Mehta J
    Bone Marrow Transplant; 1996 Dec; 18(6):1175-8. PubMed ID: 8971391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.
    Attal M; Harousseau JL; Stoppa AM; Sotto JJ; Fuzibet JG; Rossi JF; Casassus P; Maisonneuve H; Facon T; Ifrah N; Payen C; Bataille R
    N Engl J Med; 1996 Jul; 335(2):91-7. PubMed ID: 8649495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
    Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
    Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
    [No Abstract]   [Full Text] [Related]  

  • 47. Cavernosal arterial insufficiency and erectile dysfunction in recipients of high-dose chemotherapy and total body irradiation for multiple myeloma.
    Chatterjee R; Kottaridis PD; Lees WR; Ralph DJ; Goldstone AH
    Lancet; 2000 Apr; 355(9212):1335-6. PubMed ID: 10776752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
    Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW
    Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM).
    Marit G; Boiron JM; Pico JL; Foures C; Rice A; Cony-Makhoul P; Bernard P; Broustet A; Reiffers J
    Bone Marrow Transplant; 1991; 7 Suppl 2():29. PubMed ID: 1678977
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of multiple myeloma--melphalan monotherapy after bone marrow transplantation].
    Hájek R; Adam Z; Krejcí M; Vásová I; Král Z; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):278-84. PubMed ID: 8693716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
    Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
    Bone Marrow Transplant; 1999 Oct; 24(7):741-5. PubMed ID: 10516677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multiple myeloma; treatment in the year 1998].
    Lokhorst HM; Sonneveld P; Wijermans PW; Segeren CM
    Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1596-602. PubMed ID: 9763840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.
    Awedan AA
    Ann Transplant; 2002; 7(2):38-43. PubMed ID: 12416471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Intensive treatment of multiple myeloma].
    Harousseau JL
    Bull Acad Natl Med; 2003; 187(2):405-13; discussion 413-5. PubMed ID: 14556449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.
    Douer D; Levine A; Anderson WF; Gordon M; Groshen S; Khan A; Mohrbacher A; Muggia F; Shibata D
    Hum Gene Ther; 1996 Mar; 7(5):669-84. PubMed ID: 8845392
    [No Abstract]   [Full Text] [Related]  

  • 57. Recent advances in the treatment of multiple myeloma.
    Henick K; Vescio RA; Berenson JR
    Curr Opin Hematol; 1998 Jul; 5(4):254-8. PubMed ID: 9747631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I-II study.
    Tiberghien P; Cahn JY; Brion A; Deconinck E; Racadot E; Hervé P; Milpied N; Lioure B; Gluckman E; Bordigoni P; Jacob W; Chiang Y; Marcus S; Reynolds C; Longo D
    Hum Gene Ther; 1997 Mar; 8(5):615-24. PubMed ID: 9095412
    [No Abstract]   [Full Text] [Related]  

  • 59. Bone marrow and stem cell transplantation for multiple myeloma.
    Vesole DH
    Cancer Treat Res; 1999; 99():171-94. PubMed ID: 9891867
    [No Abstract]   [Full Text] [Related]  

  • 60. Autologous bone marrow transplantation for CML in which retroviral markers are used to discriminate between relapse which arises from systemic disease remaining after preparative therapy versus relapse due to residual leukemia cells in autologous marrow: a pilot trial. The University of Texas M.D. Anderson Cancer Center.
    Hum Gene Ther; 1991; 2(4):359-76. PubMed ID: 1665350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.